What they found: In normal obese mice: AOD-9604 reduced body fat by 21 % vs placebo, hGH by 24 % The AOD-9604 effect was fully dependent on the 3-adrenergic receptor , in knock-out mice no effect The hGH effect was partly independent of 3-AR , in knock-out mice there was still ~10 % fat reduction AOD-9604 did not raise IGF-1 (control level), whereas hGH raised IGF-1 by 80 % No changes in growth, organ weights (except adipose tissue), fasting insulin Why it matters: The study provided the mechanistic basis for AOD-9604 and confirmed the key business hypothesis: it is possible to separate the lipolytic effect of GH from its growth effect
An over-the-counter pain reliever will help with aches and discomfort
The drug has also been shown to reduce the risk of heart attack, stroke, and death in those with cardiovascular disease by 20 percent
Vander Heiden MG, Cantley LC, Thompson CB
In young fish, the body weight of Ex + Cr showed a slight, non-significant, increase after 6 weeks, whereas the weight of Cr and Ex did not change compared to control (Fig
Comprehensive literature searches were performed in PubMed, Web of Science, and Google Scholar (title search only) up to January 31, 2025
